

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 8.77814822 |
| 2 | negative thymic T cell selection (GO:0045060) | 8.41439335 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.15197075 |
| 4 | thymic T cell selection (GO:0045061) | 7.00518745 |
| 5 | positive thymic T cell selection (GO:0045059) | 6.96083688 |
| 6 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.88850943 |
| 7 | positive T cell selection (GO:0043368) | 6.82212394 |
| 8 | T cell selection (GO:0045058) | 6.65487914 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.51627120 |
| 10 | negative regulation of cell killing (GO:0031342) | 6.51627120 |
| 11 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.50528917 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.38235607 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.34734981 |
| 14 | interferon-gamma production (GO:0032609) | 6.34291279 |
| 15 | regulation of T cell tolerance induction (GO:0002664) | 6.10261356 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.09875487 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.09875487 |
| 18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.89475932 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 5.66439232 |
| 20 | response to interleukin-15 (GO:0070672) | 5.66390548 |
| 21 | T cell receptor signaling pathway (GO:0050852) | 5.51132218 |
| 22 | cellular response to interleukin-15 (GO:0071350) | 5.42369318 |
| 23 | leukocyte aggregation (GO:0070486) | 5.24948507 |
| 24 | T cell migration (GO:0072678) | 5.22178832 |
| 25 | T cell costimulation (GO:0031295) | 5.09583527 |
| 26 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 5.09191893 |
| 27 | positive regulation of tolerance induction (GO:0002645) | 5.06497907 |
| 28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.05280905 |
| 29 | lymphocyte costimulation (GO:0031294) | 5.02127468 |
| 30 | activated T cell proliferation (GO:0050798) | 4.92937803 |
| 31 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.83529823 |
| 32 | negative regulation of execution phase of apoptosis (GO:1900118) | 4.76669264 |
| 33 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.56795720 |
| 34 | lymphocyte chemotaxis (GO:0048247) | 4.55300735 |
| 35 | positive regulation of interleukin-2 production (GO:0032743) | 4.49823592 |
| 36 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.42612014 |
| 37 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.39803314 |
| 38 | regulation of tolerance induction (GO:0002643) | 4.39455894 |
| 39 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.34021000 |
| 40 | positive regulation of isotype switching (GO:0045830) | 4.24943226 |
| 41 | regulation of regulatory T cell differentiation (GO:0045589) | 4.23889506 |
| 42 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.07838594 |
| 43 | T cell mediated immunity (GO:0002456) | 4.01876187 |
| 44 | regulation of isotype switching (GO:0045191) | 3.97383906 |
| 45 | negative regulation of T cell mediated immunity (GO:0002710) | 3.97080328 |
| 46 | positive regulation of cell killing (GO:0031343) | 3.91880557 |
| 47 | adaptation of signaling pathway (GO:0023058) | 3.89326727 |
| 48 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.88231309 |
| 49 | respiratory burst (GO:0045730) | 3.80476606 |
| 50 | positive regulation of humoral immune response (GO:0002922) | 3.78344884 |
| 51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.78204099 |
| 52 | positive regulation of B cell mediated immunity (GO:0002714) | 3.75531693 |
| 53 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.75531693 |
| 54 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.74210086 |
| 55 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.74210086 |
| 56 | regulation of cell killing (GO:0031341) | 3.72854701 |
| 57 | chemokine-mediated signaling pathway (GO:0070098) | 3.72827871 |
| 58 | sequestering of actin monomers (GO:0042989) | 3.72815251 |
| 59 | positive regulation of T cell chemotaxis (GO:0010820) | 3.69996219 |
| 60 | regulation of T cell chemotaxis (GO:0010819) | 3.69996219 |
| 61 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.69863228 |
| 62 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.68412943 |
| 63 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.68412943 |
| 64 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.67558842 |
| 65 | tolerance induction (GO:0002507) | 3.67492579 |
| 66 | negative regulation of phagocytosis (GO:0050765) | 3.66199135 |
| 67 | alpha-beta T cell activation (GO:0046631) | 3.63750731 |
| 68 | alpha-beta T cell differentiation (GO:0046632) | 3.61475796 |
| 69 | positive regulation of DNA recombination (GO:0045911) | 3.60091492 |
| 70 | cellular defense response (GO:0006968) | 3.59737033 |
| 71 | dendritic cell chemotaxis (GO:0002407) | 3.59344439 |
| 72 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.59028067 |
| 73 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.58635837 |
| 74 | regulation of activation of Janus kinase activity (GO:0010533) | 3.58015408 |
| 75 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.57151165 |
| 76 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.56775671 |
| 77 | ribosomal small subunit assembly (GO:0000028) | 3.56159911 |
| 78 | T cell differentiation (GO:0030217) | 3.54744362 |
| 79 | mast cell activation (GO:0045576) | 3.54171077 |
| 80 | cytidine metabolic process (GO:0046087) | 3.48961440 |
| 81 | cytidine catabolic process (GO:0006216) | 3.48961440 |
| 82 | cytidine deamination (GO:0009972) | 3.48961440 |
| 83 | positive regulation of interleukin-4 production (GO:0032753) | 3.44623923 |
| 84 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.43175366 |
| 85 | regulation of B cell mediated immunity (GO:0002712) | 3.42994753 |
| 86 | cytolysis (GO:0019835) | 3.42277397 |
| 87 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.42248679 |
| 88 | regulation of immunoglobulin production (GO:0002637) | 3.41080499 |
| 89 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.39520581 |
| 90 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.36059279 |
| 91 | B cell receptor signaling pathway (GO:0050853) | 3.35530460 |
| 92 | regulation of interleukin-2 production (GO:0032663) | 3.35276180 |
| 93 | NIK/NF-kappaB signaling (GO:0038061) | 3.34535165 |
| 94 | regulation of B cell differentiation (GO:0045577) | 3.33437756 |
| 95 | regulation of defense response to virus by virus (GO:0050690) | 3.32679701 |
| 96 | regulation of calcium-mediated signaling (GO:0050848) | 3.32366562 |
| 97 | T cell activation (GO:0042110) | 3.29736112 |
| 98 | regulation of response to interferon-gamma (GO:0060330) | 3.29198989 |
| 99 | negative regulation of T cell apoptotic process (GO:0070233) | 3.28962696 |
| 100 | signal complex assembly (GO:0007172) | 3.28054594 |
| 101 | viral transcription (GO:0019083) | 3.27800657 |
| 102 | positive regulation of immunoglobulin production (GO:0002639) | 3.26967971 |
| 103 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.26691233 |
| 104 | positive regulation of B cell differentiation (GO:0045579) | 3.23863113 |
| 105 | leukocyte cell-cell adhesion (GO:0007159) | 3.21799879 |
| 106 | dendritic cell migration (GO:0036336) | 3.19952648 |
| 107 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.19852602 |
| 108 | regulation of interleukin-4 production (GO:0032673) | 3.19708689 |
| 109 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.19304000 |
| 110 | negative regulation of type 2 immune response (GO:0002829) | 3.17901542 |
| 111 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.17760436 |
| 112 | cellular response to interleukin-4 (GO:0071353) | 3.16507592 |
| 113 | translational termination (GO:0006415) | 3.15652215 |
| 114 | regulation of response to tumor cell (GO:0002834) | 3.12070286 |
| 115 | positive regulation of response to tumor cell (GO:0002836) | 3.12070286 |
| 116 | positive regulation of immune response to tumor cell (GO:0002839) | 3.12070286 |
| 117 | regulation of immune response to tumor cell (GO:0002837) | 3.12070286 |
| 118 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.11971823 |
| 119 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.11218038 |
| 120 | T cell proliferation (GO:0042098) | 3.10713166 |
| 121 | actin nucleation (GO:0045010) | 3.10237714 |
| 122 | negative regulation of interleukin-12 production (GO:0032695) | 3.09822656 |
| 123 | negative regulation of stress fiber assembly (GO:0051497) | 3.09794122 |
| 124 | ribosomal small subunit biogenesis (GO:0042274) | 3.07834533 |
| 125 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.05845262 |
| 126 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.04812430 |
| 127 | positive regulation of granulocyte differentiation (GO:0030854) | 3.03561102 |
| 128 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.02701215 |
| 129 | maturation of SSU-rRNA (GO:0030490) | 3.02152844 |
| 130 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.00447927 |
| 131 | positive regulation of T cell activation (GO:0050870) | 2.98994902 |
| 132 | lymphocyte migration (GO:0072676) | 2.98911779 |
| 133 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.97226973 |
| 134 | T cell homeostasis (GO:0043029) | 2.95012060 |
| 135 | DNA deamination (GO:0045006) | 2.94354651 |
| 136 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.93155842 |
| 137 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.90180836 |
| 138 | natural killer cell activation (GO:0030101) | 2.85309858 |
| 139 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.84781501 |
| 140 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.83278955 |
| 141 | response to interleukin-4 (GO:0070670) | 2.82457700 |
| 142 | regulation of alpha-beta T cell activation (GO:0046634) | 2.79870785 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.05773446 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.50289259 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.99622187 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.71310706 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.22659974 |
| 6 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.16896037 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.14988416 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.06778777 |
| 9 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.04799005 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.03206615 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 2.94022408 |
| 12 | MAF_26560356_Chip-Seq_TH1_Human | 2.68778394 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.62344107 |
| 14 | UTX_26944678_Chip-Seq_JUKART_Human | 2.50244623 |
| 15 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.49278267 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.45875675 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.41646351 |
| 18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.41529641 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.37246278 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.37102775 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.31183849 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.19770826 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.17359725 |
| 24 | MAF_26560356_Chip-Seq_TH2_Human | 2.16307570 |
| 25 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.09758662 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.08153957 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.06357607 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.06195997 |
| 29 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.92533992 |
| 30 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.90073570 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89210052 |
| 32 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.87297168 |
| 33 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.85019846 |
| 34 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.83999438 |
| 35 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.70880562 |
| 36 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.69016405 |
| 37 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.66422550 |
| 38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.65034410 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63093818 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62624599 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.62012219 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.61883092 |
| 43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60810898 |
| 44 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.59867400 |
| 45 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.57932758 |
| 46 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.55516502 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54970959 |
| 48 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.54228749 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.53884659 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.51040444 |
| 51 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.49379729 |
| 52 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.48605909 |
| 53 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.46721042 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45212853 |
| 55 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.44278632 |
| 56 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.39892314 |
| 57 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.32828131 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31656904 |
| 59 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29737166 |
| 60 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.28646451 |
| 61 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.25573428 |
| 62 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25042358 |
| 63 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.24324340 |
| 64 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.18091570 |
| 65 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17384587 |
| 66 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15074225 |
| 67 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14691222 |
| 68 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.14285070 |
| 69 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.13106902 |
| 70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10601963 |
| 71 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07728538 |
| 72 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.07051657 |
| 73 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.06251911 |
| 74 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05612641 |
| 75 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05455298 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05394300 |
| 77 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.04203273 |
| 78 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03641458 |
| 79 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.03384656 |
| 80 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.01676234 |
| 81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00974340 |
| 82 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00208595 |
| 83 | SPI1_23127762_ChIP-Seq_K562_Human | 0.99975438 |
| 84 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.99709424 |
| 85 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98784257 |
| 86 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98470898 |
| 87 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.98184852 |
| 88 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.97537184 |
| 89 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96311467 |
| 90 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96014287 |
| 91 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94138969 |
| 92 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92746516 |
| 93 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.92491858 |
| 94 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.92324517 |
| 95 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91823042 |
| 96 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.89348128 |
| 97 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.88631553 |
| 98 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88600742 |
| 99 | VDR_22108803_ChIP-Seq_LS180_Human | 0.88374991 |
| 100 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.88094375 |
| 101 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87256573 |
| 102 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.87104294 |
| 103 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86737362 |
| 104 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.85529297 |
| 105 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.85490173 |
| 106 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.85408466 |
| 107 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.84691695 |
| 108 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.83852537 |
| 109 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83477574 |
| 110 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82984634 |
| 111 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.82871802 |
| 112 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.82616367 |
| 113 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80888203 |
| 114 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80148021 |
| 115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80092113 |
| 116 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.79997567 |
| 117 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79992360 |
| 118 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.79699470 |
| 119 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79554141 |
| 120 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.79544569 |
| 121 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79422095 |
| 122 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.79315637 |
| 123 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.78278269 |
| 124 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.77909268 |
| 125 | GATA3_26560356_Chip-Seq_TH1_Human | 0.75264583 |
| 126 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.74758993 |
| 127 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.74609659 |
| 128 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.67462170 |
| 129 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.66695324 |
| 130 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.66401251 |
| 131 | P300_27268052_Chip-Seq_Bcells_Human | 0.65036071 |
| 132 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.64501584 |
| 133 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.63489338 |
| 134 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.63185850 |
| 135 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62887360 |
| 136 | ERA_21632823_ChIP-Seq_H3396_Human | 0.61735917 |
| 137 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.60777418 |
| 138 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.60705210 |
| 139 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.60681783 |
| 140 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60412549 |
| 141 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.60343828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 6.44850263 |
| 2 | MP0005671_abnormal_response_to | 4.50362023 |
| 3 | MP0000685_abnormal_immune_system | 3.57905549 |
| 4 | MP0009333_abnormal_splenocyte_physiolog | 3.28480423 |
| 5 | MP0000703_abnormal_thymus_morphology | 3.07589838 |
| 6 | MP0001800_abnormal_humoral_immune | 3.06001985 |
| 7 | MP0002398_abnormal_bone_marrow | 2.96287206 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.81667242 |
| 9 | MP0002420_abnormal_adaptive_immunity | 2.80572131 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.76361962 |
| 11 | MP0002166_altered_tumor_susceptibility | 2.75967137 |
| 12 | MP0001819_abnormal_immune_cell | 2.75759818 |
| 13 | MP0001790_abnormal_immune_system | 2.70886175 |
| 14 | MP0005387_immune_system_phenotype | 2.70886175 |
| 15 | MP0002723_abnormal_immune_serum | 2.70083598 |
| 16 | MP0002405_respiratory_system_inflammati | 2.65322570 |
| 17 | MP0003436_decreased_susceptibility_to | 2.54330386 |
| 18 | MP0002722_abnormal_immune_system | 2.50294570 |
| 19 | MP0000716_abnormal_immune_system | 2.50105617 |
| 20 | MP0006082_CNS_inflammation | 2.46309611 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.38966411 |
| 22 | MP0000689_abnormal_spleen_morphology | 2.38565840 |
| 23 | MP0002396_abnormal_hematopoietic_system | 2.37464565 |
| 24 | MP0003866_abnormal_defecation | 2.32761070 |
| 25 | MP0002006_tumorigenesis | 2.31200306 |
| 26 | MP0003300_gastrointestinal_ulcer | 2.30089824 |
| 27 | MP0005025_abnormal_response_to | 2.26373835 |
| 28 | MP0001873_stomach_inflammation | 2.21417600 |
| 29 | MP0003011_delayed_dark_adaptation | 2.17712573 |
| 30 | MP0009785_altered_susceptibility_to | 2.16067828 |
| 31 | MP0002429_abnormal_blood_cell | 2.05943453 |
| 32 | MP0010155_abnormal_intestine_physiology | 2.05469817 |
| 33 | MP0004947_skin_inflammation | 1.93777449 |
| 34 | MP0003303_peritoneal_inflammation | 1.88291860 |
| 35 | MP0002933_joint_inflammation | 1.84405486 |
| 36 | MP0003724_increased_susceptibility_to | 1.80810182 |
| 37 | MP0008057_abnormal_DNA_replication | 1.69226595 |
| 38 | MP0004957_abnormal_blastocyst_morpholog | 1.68408441 |
| 39 | MP0001853_heart_inflammation | 1.63310913 |
| 40 | MP0000858_altered_metastatic_potential | 1.62597279 |
| 41 | MP0002148_abnormal_hypersensitivity_rea | 1.61680164 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.52303154 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.51873568 |
| 44 | MP0004381_abnormal_hair_follicle | 1.48074314 |
| 45 | MP0002419_abnormal_innate_immunity | 1.46666910 |
| 46 | MP0003693_abnormal_embryo_hatching | 1.44473203 |
| 47 | MP0005451_abnormal_body_composition | 1.42445933 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.42176897 |
| 49 | MP0003077_abnormal_cell_cycle | 1.40491745 |
| 50 | MP0004510_myositis | 1.36590217 |
| 51 | MP0003690_abnormal_glial_cell | 1.36113815 |
| 52 | MP0003191_abnormal_cellular_cholesterol | 1.33873010 |
| 53 | MP0003448_altered_tumor_morphology | 1.31626701 |
| 54 | MP0010352_gastrointestinal_tract_polyps | 1.29508747 |
| 55 | MP0010094_abnormal_chromosome_stability | 1.24602677 |
| 56 | MP0000490_abnormal_crypts_of | 1.24538905 |
| 57 | MP0005166_decreased_susceptibility_to | 1.23396109 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 1.23087134 |
| 59 | MP0002019_abnormal_tumor_incidence | 1.22115688 |
| 60 | MP0005075_abnormal_melanosome_morpholog | 1.21913085 |
| 61 | MP0002277_abnormal_respiratory_mucosa | 1.20444956 |
| 62 | MP0003111_abnormal_nucleus_morphology | 1.14704053 |
| 63 | MP0002132_abnormal_respiratory_system | 1.12385812 |
| 64 | MP0005310_abnormal_salivary_gland | 1.09655775 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 1.09286556 |
| 66 | MP0005023_abnormal_wound_healing | 1.08361637 |
| 67 | MP0008961_abnormal_basal_metabolism | 0.98489785 |
| 68 | MP0005379_endocrine/exocrine_gland_phen | 0.96441522 |
| 69 | MP0001533_abnormal_skeleton_physiology | 0.92403284 |
| 70 | MP0008260_abnormal_autophagy | 0.91264292 |
| 71 | MP0008469_abnormal_protein_level | 0.89445031 |
| 72 | MP0001545_abnormal_hematopoietic_system | 0.87698528 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 0.87698528 |
| 74 | MP0002693_abnormal_pancreas_physiology | 0.85934243 |
| 75 | MP0003329_amyloid_beta_deposits | 0.85756468 |
| 76 | MP0008058_abnormal_DNA_repair | 0.83318704 |
| 77 | MP0005076_abnormal_cell_differentiation | 0.80836028 |
| 78 | MP0000350_abnormal_cell_proliferation | 0.80214686 |
| 79 | MP0002009_preneoplasia | 0.79071847 |
| 80 | MP0001851_eye_inflammation | 0.76133237 |
| 81 | MP0001730_embryonic_growth_arrest | 0.75957762 |
| 82 | MP0003183_abnormal_peptide_metabolism | 0.75547421 |
| 83 | MP0001542_abnormal_bone_strength | 0.73342255 |
| 84 | MP0002163_abnormal_gland_morphology | 0.72810098 |
| 85 | MP0009764_decreased_sensitivity_to | 0.72522884 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.71686444 |
| 87 | MP0000477_abnormal_intestine_morphology | 0.71129958 |
| 88 | MP0003252_abnormal_bile_duct | 0.70732461 |
| 89 | MP0001348_abnormal_lacrimal_gland | 0.70453426 |
| 90 | MP0008007_abnormal_cellular_replicative | 0.70404888 |
| 91 | MP0004883_abnormal_blood_vessel | 0.70346895 |
| 92 | MP0002998_abnormal_bone_remodeling | 0.67073773 |
| 93 | MP0002138_abnormal_hepatobiliary_system | 0.66946495 |
| 94 | MP0000313_abnormal_cell_death | 0.64940757 |
| 95 | MP0009763_increased_sensitivity_to | 0.64407915 |
| 96 | MP0004185_abnormal_adipocyte_glucose | 0.64094705 |
| 97 | MP0005645_abnormal_hypothalamus_physiol | 0.63935393 |
| 98 | MP0000920_abnormal_myelination | 0.63115585 |
| 99 | MP0004130_abnormal_muscle_cell | 0.62856605 |
| 100 | MP0001765_abnormal_ion_homeostasis | 0.61962197 |
| 101 | MP0002168_other_aberrant_phenotype | 0.61919191 |
| 102 | MP0000604_amyloidosis | 0.60988865 |
| 103 | MP0001243_abnormal_dermal_layer | 0.57969961 |
| 104 | MP0002086_abnormal_extraembryonic_tissu | 0.57359310 |
| 105 | MP0009643_abnormal_urine_homeostasis | 0.56934263 |
| 106 | MP0003137_abnormal_impulse_conducting | 0.55810686 |
| 107 | MP0003795_abnormal_bone_structure | 0.54861369 |
| 108 | MP0002080_prenatal_lethality | 0.51590365 |
| 109 | MP0003045_fibrosis | 0.51472628 |
| 110 | MP0000609_abnormal_liver_physiology | 0.51111475 |
| 111 | MP0005164_abnormal_response_to | 0.50344772 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.50302489 |
| 113 | MP0008872_abnormal_physiological_respon | 0.50046586 |
| 114 | MP0008873_increased_physiological_sensi | 0.49227756 |
| 115 | MP0003075_altered_response_to | 0.48563282 |
| 116 | MP0004145_abnormal_muscle_electrophysio | 0.47427930 |
| 117 | MP0008770_decreased_survivor_rate | 0.46260821 |
| 118 | MP0002088_abnormal_embryonic_growth/wei | 0.45490959 |
| 119 | MP0001216_abnormal_epidermal_layer | 0.45315901 |
| 120 | MP0009642_abnormal_blood_homeostasis | 0.44784517 |
| 121 | MP0003091_abnormal_cell_migration | 0.44725061 |
| 122 | MP0003984_embryonic_growth_retardation | 0.44380147 |
| 123 | MP0005380_embryogenesis_phenotype | 0.44090454 |
| 124 | MP0001672_abnormal_embryogenesis/_devel | 0.44090454 |
| 125 | MP0003786_premature_aging | 0.43864928 |
| 126 | MP0005390_skeleton_phenotype | 0.42645954 |
| 127 | MP0002837_dystrophic_cardiac_calcinosis | 0.42433648 |
| 128 | MP0003646_muscle_fatigue | 0.42185873 |
| 129 | MP0002822_catalepsy | 0.41669725 |
| 130 | MP0001697_abnormal_embryo_size | 0.41656350 |
| 131 | MP0000372_irregular_coat_pigmentation | 0.41526656 |
| 132 | MP0002136_abnormal_kidney_physiology | 0.41335008 |
| 133 | MP0003453_abnormal_keratinocyte_physiol | 0.40689122 |
| 134 | MP0002083_premature_death | 0.40604844 |
| 135 | MP0000249_abnormal_blood_vessel | 0.40406598 |
| 136 | MP0008569_lethality_at_weaning | 0.36585804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 8.75158892 |
| 2 | Abnormality of T cell number (HP:0011839) | 8.36319645 |
| 3 | Stomatitis (HP:0010280) | 6.09506915 |
| 4 | Abnormality of T cells (HP:0002843) | 5.95968441 |
| 5 | Combined immunodeficiency (HP:0005387) | 5.87684517 |
| 6 | Severe combined immunodeficiency (HP:0004430) | 5.84684439 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.81775956 |
| 8 | Aplastic anemia (HP:0001915) | 5.22088346 |
| 9 | Nasal polyposis (HP:0100582) | 4.70577586 |
| 10 | Recurrent bronchitis (HP:0002837) | 4.67618807 |
| 11 | Panhypogammaglobulinemia (HP:0003139) | 4.66344097 |
| 12 | Recurrent viral infections (HP:0004429) | 4.58187729 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.51557231 |
| 14 | IgG deficiency (HP:0004315) | 4.44486179 |
| 15 | Recurrent fungal infections (HP:0002841) | 4.34170030 |
| 16 | Acute hepatic failure (HP:0006554) | 4.29219297 |
| 17 | Chronic otitis media (HP:0000389) | 4.20756337 |
| 18 | IgM deficiency (HP:0002850) | 4.16317177 |
| 19 | Abnormality of eosinophils (HP:0001879) | 4.01905167 |
| 20 | Eosinophilia (HP:0001880) | 4.01242906 |
| 21 | Pustule (HP:0200039) | 3.88438767 |
| 22 | Increased IgM level (HP:0003496) | 3.85726141 |
| 23 | Abnormality of the nasal mucosa (HP:0000433) | 3.83734305 |
| 24 | Granulocytopenia (HP:0001913) | 3.72064086 |
| 25 | Eczematoid dermatitis (HP:0000976) | 3.60819519 |
| 26 | Recurrent bacterial skin infections (HP:0005406) | 3.60495760 |
| 27 | Abnormality of T cell physiology (HP:0011840) | 3.54608440 |
| 28 | Leukocytosis (HP:0001974) | 3.53061798 |
| 29 | Joint swelling (HP:0001386) | 3.51781105 |
| 30 | B lymphocytopenia (HP:0010976) | 3.46035040 |
| 31 | Abnormality of B cell number (HP:0010975) | 3.46035040 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.45677111 |
| 33 | Lymphopenia (HP:0001888) | 3.42735325 |
| 34 | Basal cell carcinoma (HP:0002671) | 3.42354498 |
| 35 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.36614974 |
| 36 | Abnormality of the fingertips (HP:0001211) | 3.35553041 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 3.33863631 |
| 38 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.33863631 |
| 39 | Chronic diarrhea (HP:0002028) | 3.23559082 |
| 40 | Myositis (HP:0100614) | 3.21418530 |
| 41 | Autoimmune hemolytic anemia (HP:0001890) | 3.17624637 |
| 42 | Thrombocytosis (HP:0001894) | 3.13145522 |
| 43 | Hypoproteinemia (HP:0003075) | 3.03426596 |
| 44 | Gastrointestinal infarctions (HP:0005244) | 2.98868445 |
| 45 | Autoimmune thrombocytopenia (HP:0001973) | 2.97372113 |
| 46 | Lymphoma (HP:0002665) | 2.93168049 |
| 47 | IgA deficiency (HP:0002720) | 2.88065618 |
| 48 | Hypochromic microcytic anemia (HP:0004840) | 2.85234870 |
| 49 | Keratoconjunctivitis sicca (HP:0001097) | 2.73424623 |
| 50 | Thyroiditis (HP:0100646) | 2.68896963 |
| 51 | Bronchitis (HP:0012387) | 2.67921818 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.64235113 |
| 53 | Agammaglobulinemia (HP:0004432) | 2.59747423 |
| 54 | Keratoconjunctivitis (HP:0001096) | 2.54052930 |
| 55 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.53614140 |
| 56 | Hypergammaglobulinemia (HP:0010702) | 2.49309384 |
| 57 | Cerebral palsy (HP:0100021) | 2.46581385 |
| 58 | 3-Methylglutaconic aciduria (HP:0003535) | 2.45262292 |
| 59 | Hemoptysis (HP:0002105) | 2.43221099 |
| 60 | Spontaneous hematomas (HP:0007420) | 2.40979783 |
| 61 | Congenital stationary night blindness (HP:0007642) | 2.40489402 |
| 62 | Amaurosis fugax (HP:0100576) | 2.40137843 |
| 63 | Encephalitis (HP:0002383) | 2.39352303 |
| 64 | Recurrent sinusitis (HP:0011108) | 2.35321711 |
| 65 | Mediastinal lymphadenopathy (HP:0100721) | 2.31932011 |
| 66 | Broad face (HP:0000283) | 2.30216688 |
| 67 | Vasculitis (HP:0002633) | 2.29713153 |
| 68 | Hypoplasia of the thymus (HP:0000778) | 2.28851691 |
| 69 | Meningitis (HP:0001287) | 2.28116011 |
| 70 | Increased IgE level (HP:0003212) | 2.26601220 |
| 71 | Chest pain (HP:0100749) | 2.25568251 |
| 72 | Loss of speech (HP:0002371) | 2.24518041 |
| 73 | Recurrent otitis media (HP:0000403) | 2.22775963 |
| 74 | Increased density of long bones (HP:0006392) | 2.22000085 |
| 75 | Tetany (HP:0001281) | 2.20930181 |
| 76 | Pulmonary infiltrates (HP:0002113) | 2.19210645 |
| 77 | Ureteral stenosis (HP:0000071) | 2.17249929 |
| 78 | Obstructive lung disease (HP:0006536) | 2.13102414 |
| 79 | Chronic obstructive pulmonary disease (HP:0006510) | 2.13102414 |
| 80 | Gingivitis (HP:0000230) | 2.12932371 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 2.10382227 |
| 82 | Cheilitis (HP:0100825) | 2.08554446 |
| 83 | Inflammation of the large intestine (HP:0002037) | 2.08310344 |
| 84 | Chronic sinusitis (HP:0011109) | 2.07647833 |
| 85 | Hemiplegia (HP:0002301) | 2.07489266 |
| 86 | Anorexia (HP:0002039) | 2.07160355 |
| 87 | Retrobulbar optic neuritis (HP:0100654) | 2.06078862 |
| 88 | Optic neuritis (HP:0100653) | 2.06078862 |
| 89 | Oral leukoplakia (HP:0002745) | 2.05618989 |
| 90 | Gangrene (HP:0100758) | 2.03603648 |
| 91 | Abnormal platelet volume (HP:0011876) | 2.03181904 |
| 92 | Cellular immunodeficiency (HP:0005374) | 2.03163181 |
| 93 | Multiple enchondromatosis (HP:0005701) | 2.03026281 |
| 94 | Increased CSF protein (HP:0002922) | 2.00046953 |
| 95 | Papilloma (HP:0012740) | 1.99851059 |
| 96 | Verrucae (HP:0200043) | 1.99851059 |
| 97 | Hyperlipoproteinemia (HP:0010980) | 1.98930815 |
| 98 | Hypochromic anemia (HP:0001931) | 1.98191350 |
| 99 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.97217582 |
| 100 | Reticulocytopenia (HP:0001896) | 1.94526674 |
| 101 | Bronchiectasis (HP:0002110) | 1.93854923 |
| 102 | Ureteral obstruction (HP:0006000) | 1.93379341 |
| 103 | Trigonocephaly (HP:0000243) | 1.93329168 |
| 104 | Poikiloderma (HP:0001029) | 1.92565700 |
| 105 | Posterior subcapsular cataract (HP:0007787) | 1.91309573 |
| 106 | Petechiae (HP:0000967) | 1.91153920 |
| 107 | Arterial thrombosis (HP:0004420) | 1.88727028 |
| 108 | Dislocated radial head (HP:0003083) | 1.88072887 |
| 109 | Abnormality of the prostate (HP:0008775) | 1.88047889 |
| 110 | Colitis (HP:0002583) | 1.88023614 |
| 111 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.87912183 |
| 112 | Epistaxis (HP:0000421) | 1.87356665 |
| 113 | Colon cancer (HP:0003003) | 1.85395787 |
| 114 | Seborrheic dermatitis (HP:0001051) | 1.83744427 |
| 115 | Amyotrophic lateral sclerosis (HP:0007354) | 1.83118461 |
| 116 | Spinal canal stenosis (HP:0003416) | 1.82768686 |
| 117 | Long clavicles (HP:0000890) | 1.81737249 |
| 118 | Acne (HP:0001061) | 1.81520697 |
| 119 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.81408132 |
| 120 | Keratitis (HP:0000491) | 1.80246155 |
| 121 | Abnormality of oral frenula (HP:0000190) | 1.78123339 |
| 122 | Orchitis (HP:0100796) | 1.77632833 |
| 123 | Microcytic anemia (HP:0001935) | 1.75785133 |
| 124 | J-shaped sella turcica (HP:0002680) | 1.75316151 |
| 125 | Recurrent abscess formation (HP:0002722) | 1.75129254 |
| 126 | Abnormality of the radial head (HP:0003995) | 1.74526963 |
| 127 | Recurrent skin infections (HP:0001581) | 1.73958991 |
| 128 | Sepsis (HP:0100806) | 1.73691053 |
| 129 | Pulmonary embolism (HP:0002204) | 1.70254407 |
| 130 | Persistence of primary teeth (HP:0006335) | 1.69574790 |
| 131 | Hepatitis (HP:0012115) | 1.68518168 |
| 132 | Premature graying of hair (HP:0002216) | 1.68221281 |
| 133 | Bicuspid aortic valve (HP:0001647) | 1.68044534 |
| 134 | Abnormal number of erythroid precursors (HP:0012131) | 1.66284546 |
| 135 | Increased mean platelet volume (HP:0011877) | 1.65253807 |
| 136 | Pancytopenia (HP:0001876) | 1.64613419 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.94912147 |
| 2 | MAP4K1 | 6.10865309 |
| 3 | ITK | 3.54896981 |
| 4 | ZAP70 | 3.51101482 |
| 5 | SCYL2 | 3.50245726 |
| 6 | STK10 | 3.14090784 |
| 7 | JAK3 | 3.13364384 |
| 8 | FGFR4 | 2.75736705 |
| 9 | GRK7 | 2.61559018 |
| 10 | TAOK3 | 2.33759695 |
| 11 | RIPK4 | 2.29386152 |
| 12 | TYK2 | 2.25686422 |
| 13 | IKBKE | 2.18968255 |
| 14 | GRK6 | 2.14370570 |
| 15 | TAF1 | 2.05290664 |
| 16 | NLK | 2.00598052 |
| 17 | LCK | 1.95190881 |
| 18 | MST4 | 1.72935240 |
| 19 | TESK2 | 1.71676743 |
| 20 | TEC | 1.71465623 |
| 21 | FGFR3 | 1.66595923 |
| 22 | ERN1 | 1.63897258 |
| 23 | CSK | 1.63555449 |
| 24 | MAP3K14 | 1.57373338 |
| 25 | NME2 | 1.53803373 |
| 26 | EEF2K | 1.52560586 |
| 27 | JAK1 | 1.48677546 |
| 28 | CAMKK2 | 1.47620967 |
| 29 | MAP3K12 | 1.47463837 |
| 30 | RPS6KA4 | 1.31242438 |
| 31 | CDK12 | 1.29715818 |
| 32 | MOS | 1.27974216 |
| 33 | MARK3 | 1.27060601 |
| 34 | HCK | 1.26577298 |
| 35 | SYK | 1.24026270 |
| 36 | PRKCQ | 1.21821380 |
| 37 | TAOK1 | 1.21031795 |
| 38 | CAMKK1 | 1.20628544 |
| 39 | LRRK2 | 1.19849479 |
| 40 | MAP3K10 | 1.17801924 |
| 41 | NEK6 | 1.14935995 |
| 42 | IKBKB | 1.14425114 |
| 43 | BTK | 1.13614468 |
| 44 | PKN2 | 1.10994170 |
| 45 | KDR | 1.10158005 |
| 46 | PRKCH | 1.07720565 |
| 47 | PIM1 | 1.04033410 |
| 48 | TYRO3 | 1.03428148 |
| 49 | PASK | 1.03099709 |
| 50 | MAP3K13 | 1.02763445 |
| 51 | EIF2AK3 | 0.99561340 |
| 52 | TBK1 | 0.98886480 |
| 53 | WNK4 | 0.96898739 |
| 54 | GRK5 | 0.96127596 |
| 55 | BLK | 0.92844987 |
| 56 | CHUK | 0.90402364 |
| 57 | FGR | 0.89796323 |
| 58 | RPS6KB2 | 0.88033864 |
| 59 | ALK | 0.76416462 |
| 60 | MAP3K7 | 0.72664282 |
| 61 | JAK2 | 0.71524853 |
| 62 | TRPM7 | 0.70859206 |
| 63 | TLK1 | 0.70720639 |
| 64 | MELK | 0.68210656 |
| 65 | CDK4 | 0.67426983 |
| 66 | CDC7 | 0.67379749 |
| 67 | FGFR1 | 0.66369095 |
| 68 | CLK1 | 0.64853550 |
| 69 | FES | 0.64746983 |
| 70 | LIMK1 | 0.63799522 |
| 71 | LYN | 0.63215406 |
| 72 | MAP3K8 | 0.62736426 |
| 73 | MAP2K3 | 0.62716302 |
| 74 | TRIB3 | 0.59110997 |
| 75 | SIK2 | 0.57637193 |
| 76 | NTRK2 | 0.56969563 |
| 77 | KIT | 0.55522791 |
| 78 | RPS6KA5 | 0.54646845 |
| 79 | BRD4 | 0.54490257 |
| 80 | STK4 | 0.54452838 |
| 81 | MARK2 | 0.54006196 |
| 82 | TGFBR1 | 0.53250666 |
| 83 | IRAK4 | 0.52797608 |
| 84 | PDGFRB | 0.51939095 |
| 85 | PTK6 | 0.51754916 |
| 86 | GRK1 | 0.51376096 |
| 87 | NEK2 | 0.49453757 |
| 88 | MAPK7 | 0.49439070 |
| 89 | BUB1 | 0.49400909 |
| 90 | INSR | 0.47317052 |
| 91 | ADRBK2 | 0.46588394 |
| 92 | TNK2 | 0.46425534 |
| 93 | ACVR1B | 0.44682935 |
| 94 | MAP3K11 | 0.42414738 |
| 95 | PRPF4B | 0.41544564 |
| 96 | SRPK1 | 0.40309860 |
| 97 | TSSK6 | 0.39878919 |
| 98 | ROCK2 | 0.39750299 |
| 99 | PDK1 | 0.39529466 |
| 100 | TTN | 0.39478970 |
| 101 | MAP2K6 | 0.38952588 |
| 102 | CSF1R | 0.37385951 |
| 103 | EPHB1 | 0.37108759 |
| 104 | HIPK2 | 0.36776020 |
| 105 | TGFBR2 | 0.36736261 |
| 106 | MAPKAPK2 | 0.36624229 |
| 107 | EPHA3 | 0.36046872 |
| 108 | ILK | 0.35912243 |
| 109 | CHEK1 | 0.34994705 |
| 110 | ERBB3 | 0.34489960 |
| 111 | FLT3 | 0.34281839 |
| 112 | FYN | 0.34122546 |
| 113 | MAP2K2 | 0.33561133 |
| 114 | MYLK | 0.33319893 |
| 115 | MAP3K3 | 0.32880578 |
| 116 | TAOK2 | 0.31954374 |
| 117 | PLK4 | 0.30255381 |
| 118 | IGF1R | 0.29335091 |
| 119 | SIK3 | 0.29174277 |
| 120 | PIK3CG | 0.28298968 |
| 121 | ATR | 0.27339503 |
| 122 | CDK6 | 0.27074747 |
| 123 | PIM2 | 0.25821003 |
| 124 | PTK2B | 0.24979009 |
| 125 | PRKD2 | 0.24612644 |
| 126 | MAPK11 | 0.22234936 |
| 127 | ROCK1 | 0.21870844 |
| 128 | DAPK1 | 0.21840703 |
| 129 | RPS6KA6 | 0.21761683 |
| 130 | STK39 | 0.21623512 |
| 131 | ADRBK1 | 0.21260653 |
| 132 | MAPK15 | 0.21013045 |
| 133 | STK11 | 0.20165638 |
| 134 | CSNK2A2 | 0.19588742 |
| 135 | TESK1 | 0.19536603 |
| 136 | MAPK3 | 0.19148525 |
| 137 | RAF1 | 0.18555005 |
| 138 | EGFR | 0.18447770 |
| 139 | CDK2 | 0.18423480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.84185258 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.37289677 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.75677849 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.74254837 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.69920195 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.69587243 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.67823790 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.51388972 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.49515785 |
| 10 | Ribosome_Homo sapiens_hsa03010 | 2.37240291 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.32572751 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.13303494 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.99008901 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.87276450 |
| 15 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.72961242 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.68307393 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.63264896 |
| 18 | Spliceosome_Homo sapiens_hsa03040 | 1.62049339 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.60475610 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.50603905 |
| 21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.50237166 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.49658218 |
| 23 | DNA replication_Homo sapiens_hsa03030 | 1.46345711 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.39325411 |
| 25 | Mismatch repair_Homo sapiens_hsa03430 | 1.38631529 |
| 26 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.37716387 |
| 27 | HTLV-I infection_Homo sapiens_hsa05166 | 1.28514379 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.26941326 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.23398810 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.23107320 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.20919751 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.19252920 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19132568 |
| 34 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.17402344 |
| 35 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.17166249 |
| 36 | RNA transport_Homo sapiens_hsa03013 | 1.16485922 |
| 37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.13320800 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.08993568 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08895643 |
| 40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07623392 |
| 41 | Asthma_Homo sapiens_hsa05310 | 1.03200111 |
| 42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.02255468 |
| 43 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.99276318 |
| 44 | Colorectal cancer_Homo sapiens_hsa05210 | 0.98936148 |
| 45 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.98673619 |
| 46 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.93784164 |
| 47 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.93261417 |
| 48 | Base excision repair_Homo sapiens_hsa03410 | 0.92368943 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 0.92031951 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 0.91041823 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90972883 |
| 52 | RNA polymerase_Homo sapiens_hsa03020 | 0.84245885 |
| 53 | RNA degradation_Homo sapiens_hsa03018 | 0.83850280 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83720413 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83693053 |
| 56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83155014 |
| 57 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.82974611 |
| 58 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.81210053 |
| 59 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.81187204 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 0.79026106 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79005487 |
| 62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78568655 |
| 63 | Proteasome_Homo sapiens_hsa03050 | 0.77092530 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74388033 |
| 65 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.71531128 |
| 66 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.71450710 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 0.70406756 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66511057 |
| 69 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.65848575 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65784887 |
| 71 | Renin secretion_Homo sapiens_hsa04924 | 0.65627738 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.64634557 |
| 73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64354380 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.59586161 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58927913 |
| 76 | Thyroid cancer_Homo sapiens_hsa05216 | 0.56026970 |
| 77 | Cell cycle_Homo sapiens_hsa04110 | 0.55435677 |
| 78 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.54464571 |
| 79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52901786 |
| 80 | Tuberculosis_Homo sapiens_hsa05152 | 0.50684422 |
| 81 | Homologous recombination_Homo sapiens_hsa03440 | 0.50601735 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50577821 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49375880 |
| 84 | Salmonella infection_Homo sapiens_hsa05132 | 0.48075781 |
| 85 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.47572322 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46892904 |
| 87 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.46882229 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46515288 |
| 89 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.45824064 |
| 90 | Phototransduction_Homo sapiens_hsa04744 | 0.45328578 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44716502 |
| 92 | Malaria_Homo sapiens_hsa05144 | 0.44484745 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43274803 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42499720 |
| 95 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.41159256 |
| 96 | Pertussis_Homo sapiens_hsa05133 | 0.40899096 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.37034127 |
| 98 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.35868855 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35800199 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.34597988 |
| 101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34522368 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33751821 |
| 103 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.33685619 |
| 104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33347425 |
| 105 | Basal transcription factors_Homo sapiens_hsa03022 | 0.33254155 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32905011 |
| 107 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.32337321 |
| 108 | Parkinsons disease_Homo sapiens_hsa05012 | 0.31794968 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29852086 |
| 110 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.29539770 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29068733 |
| 112 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.28090501 |
| 113 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.26558658 |
| 114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.24679449 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.24439133 |
| 116 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23934622 |
| 117 | Olfactory transduction_Homo sapiens_hsa04740 | 0.23019989 |
| 118 | Endometrial cancer_Homo sapiens_hsa05213 | 0.22985353 |
| 119 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.20898725 |
| 120 | ABC transporters_Homo sapiens_hsa02010 | 0.19622965 |
| 121 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.18999624 |
| 122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.18861071 |
| 123 | Morphine addiction_Homo sapiens_hsa05032 | 0.18768014 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18570667 |
| 125 | Alzheimers disease_Homo sapiens_hsa05010 | 0.18415594 |
| 126 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.13890797 |
| 127 | Phagosome_Homo sapiens_hsa04145 | 0.12961977 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.11068370 |
| 129 | Mineral absorption_Homo sapiens_hsa04978 | 0.10856416 |
| 130 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.10725181 |
| 131 | Long-term potentiation_Homo sapiens_hsa04720 | 0.10568829 |
| 132 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.10411513 |
| 133 | Retinol metabolism_Homo sapiens_hsa00830 | 0.09677461 |

